Article

<i>Mtfp1</i> ablation enhances mitochondrial respiration and protects against hepatic steatosis

2023-04-28

Abstract excerpt

Hepatic steatosis is the result of an imbalance between nutrient delivery and metabolism in the liver. It is the first hallmark of Non-alcoholic fatty liver disease (NAFLD) and is characterized by the accumulation of excess lipids in the liver that can drive liver failure, inflammation, and cancer. Mitochondria control the fate and function of cells and compelling evidence implicates these multifunctional organell...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 53cb70fc-708c-5a3e-a860-79a753285989
DOI: 10.1101/2023.04.26.538374

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

<i>Mtfp1</i> ablation enhances mitochondrial respiration and protects against hepatic steatosisDOI 10.1101/2023.04.26.538374Read

Mitochondrial fission process 1 (MTFP1) controls bioenergetic efficiency and prevents inflammatory cardiomyopathy and heart failure in miceSemantic proximity Read

Analysis of the Mitochondrial Dynamics in NAFLD: Drp1 as a Marker of Inflammation and FibrosisSemantic proximity Read

Mitochondrial Dysfunction Induces Hepatic Lipid Accumulation and Inflammatory Responses in mtDNA Mutator MiceSemantic proximity Read

Circadian gene Clock regulates mitochondrial morphology and functions by posttranscriptional waySemantic proximity Read

Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read

Decreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver disease.Semantic proximity Read

Dynamin-related protein 1 deficiency impairs mitophagy and accelerates lipopolysaccharide-induced inflammation in miceSemantic proximity Read

Reduced mitophagy is an early feature of NAFLD and liver-specific PARKIN knockout hastens the onset of steatosis, inflammation and fibrosisSemantic proximity Read

Loss of mitochondrial amidoxime-reducing component 1 (mARC1) prevents disease progression by reducing fibrosis in multiple mouse models of chronic liver diseaseSemantic proximity Read

Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCCSemantic proximity Read

Mitochondrial dysfunction and liver disease: role, relevance, and potential for therapeutic modulationSemantic proximity Read

Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver DiseaseSemantic proximity Read